KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.45 $1.68 Friday, 27th Jan 2023 CLSN stock ended at $1.56. This is 4.00% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 7.38% from a day low at $1.49 to a day high of $1.60.
90 days $1.45 $1.68
52 weeks $0.370 $7.68

Historical Celsion Corporation prices

Date Open High Low Close Volume
Sep 12, 2019 $1.68 $1.74 $1.68 $1.71 69 418
Sep 11, 2019 $1.79 $1.81 $1.68 $1.71 174 386
Sep 10, 2019 $1.78 $1.80 $1.75 $1.75 115 048
Sep 09, 2019 $1.78 $1.84 $1.77 $1.78 67 703
Sep 06, 2019 $1.80 $1.81 $1.75 $1.79 42 855
Sep 05, 2019 $1.80 $1.84 $1.77 $1.80 33 383
Sep 04, 2019 $1.81 $1.82 $1.76 $1.80 42 934
Sep 03, 2019 $1.81 $1.86 $1.79 $1.79 38 787
Aug 30, 2019 $1.80 $1.86 $1.80 $1.83 37 302
Aug 29, 2019 $1.81 $1.83 $1.75 $1.81 107 189
Aug 28, 2019 $1.80 $1.84 $1.75 $1.81 32 332
Aug 27, 2019 $1.82 $1.86 $1.75 $1.79 135 409
Aug 26, 2019 $1.82 $1.84 $1.78 $1.78 76 265
Aug 23, 2019 $1.88 $1.90 $1.82 $1.82 56 813
Aug 22, 2019 $1.90 $1.90 $1.85 $1.90 32 701
Aug 21, 2019 $1.89 $1.90 $1.86 $1.90 106 732
Aug 20, 2019 $1.82 $1.90 $1.79 $1.90 73 389
Aug 19, 2019 $1.83 $1.90 $1.81 $1.81 157 661
Aug 16, 2019 $1.71 $1.83 $1.70 $1.80 121 393
Aug 15, 2019 $1.65 $1.79 $1.64 $1.70 98 499
Aug 14, 2019 $1.64 $1.69 $1.60 $1.69 64 193
Aug 13, 2019 $1.72 $1.74 $1.62 $1.69 86 568
Aug 12, 2019 $1.66 $1.70 $1.60 $1.70 59 416
Aug 09, 2019 $1.72 $1.72 $1.55 $1.68 210 314
Aug 08, 2019 $1.79 $1.79 $1.69 $1.69 63 913
Click to get the best stock tips daily for free!

About Celsion Corporation

Celsion Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company als... CLSN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT